Department of Orthopaedic Surgery, Kyungpook National University College of Medicine, Kyungpook National University Hospital, Daegu, Korea.
Arch Orthop Trauma Surg. 2010 Nov;130(11):1329-33. doi: 10.1007/s00402-009-1026-2. Epub 2009 Dec 18.
There have been not much reports on the result of intralesional excision for giant cell tumors (GCTs) of the femoral head and neck because of its rarity. The purpose of this study is to review the results of patients managed with intralesional curettage for GCT of the femoral head and neck.
We retrospectively reviewed 12 patients with a GCT of the femoral head and/or neck. All of them were treated with curettage and followed up to monitor local recurrence and pulmonary metastasis. Mean duration of follow-up was 58.3 months.
Although recurrence rate of the present study was rather high (41.7%, 5 of 12 hips), 9 of 12 hips (75%) were preserved at last follow-up including 2 hips that underwent repeat curettage, and functional outcomes of the preserved hips were satisfactory.
It may be that curettage should be considered as a primary treatment of choice for GCTs of the femoral head and neck.
由于股骨颈部位的骨巨细胞瘤（GCT）较为罕见，因此针对该部位 GCT 行瘤内切除的相关研究报道较少。本研究旨在回顾分析采用瘤内刮除术治疗股骨颈 GCT 的患者的治疗效果。
本研究回顾性分析了 12 例股骨颈 GCT 患者的临床资料。所有患者均接受了刮除术治疗，并进行了随访以监测局部复发和肺转移情况。平均随访时间为 58.3 个月。
尽管本研究的复发率较高（41.7%，12 髋中有 5 髋），但在末次随访时，12 髋中有 9 髋（75%）得到了保留，包括 2 髋接受了再次刮除，保留髋关节的功能结局满意。
对于股骨颈 GCT，刮除术可能是一种较好的初始治疗选择。
